MIDAS Catalog

MIDAS

Created by Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention (CDC) no longer provides access to the data set.
Description:

CDC is partnering with commercial laboratories to conduct and publish results of a seroprevalence survey that has tested de-identified clinical blood specimens for SARS-CoV-2 antibodies. The survey includes people who had blood specimens tested for reasons unrelated to COVID-19, such as for a routine or sick visit during which blood was collected and tested by commercial laboratories in participating areas from each of the 10 sites. CDC aims to test about 1,800 samples collected from each of 10 areas, approximately every 3–4 weeks.

Preview:
https://covid.cdc.gov/covid-data-tracker/#serology-surveillance

Centers for Disease Control and Prevention (CDC) no longer provides access to the data set. The image below represents an archived version of when the data set was accessible.

image
IdentifierURL:https://covid.cdc.gov/covid-data-tracker/#serology-surveillance
Typedata set
Biological Scalepopulation
Collection End Date2020/07/30
LanguageEnglish
Topics
  • case counts
    • diagnostic tests
  • disease
    • infectious disease
      • COVID-19
  • host organism
    • Homo sapiens
  • pathogen
    • Severe acute respiratory syndrome coronavirus 2
  • population demographic census
Geographical ScopeLouisiana, Utah, Minnesota, Washington, Florida, Connecticut, Missouri, California, Pennsylvania, New York
Geographical ResolutionCity, State
Start Date2020/03/23
End Date
Versionunspecified
Accessible For FreeTRUE
Licenseunspecified
Rightsunspecified
HTTP Status CodeNA
HTTP Checked OnNA